Vertex transformed cystic fibrosis treatment with its CFTR modulator franchise and is expanding into pain, kidney disease, and gene-edited cell therapies. It collaborates with the Cystic Fibrosis Foundation and academic labs on structure-based drug design.
R&D SPEND
$3.3B
INDUSTRY
Biotech180
ACADEMIC COLLABORATIONS
4200
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED